Uptake of tritiated methotrexate by mouse brain tumors after intravenous or intrathecal administration.
D000818:Animals; D001345:Autoradiography; D001812:Blood-Brain Barrier; D001921:Brain / Q000378:metabolism; D001932:Brain Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000378:metabolism; D005910:Glioma / Q000188:drug therapy / Q000378:metabolism*; D007275:Injections, Intravenous; D007278:Injections, Spinal; D008727:Methotrexate / Q000008:administration & dosage / Q000378:metabolism* / Q000627:therapeutic use; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000188:drug therapy; D012509:Sarcoma / Q000188:drug therapy / Q000378:metabolism; D012888:Skull Neoplasms / Q000188:drug therapy / Q000378:metabolism; D014316:Tritium
D014316:Tritium; D008727:Methotrexate